| fungalAi for Fungal Surveillance & Antifungal Stewardship (NCT03793231) | Bayside Health | 2019-01-01 |
| Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers (NCT02631954) | Chong Kun Dang Pharmaceutical | 2015-09-01 |
| Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children (NCT02358499) | Children's Mercy Hospital Kansas City | 2015-01-01 |
| MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial (NCT02306330) | Oxford University Clinical Research Unit, Vietnam | 2014-12-01 |
| Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis (NCT02025699) | MeMed Diagnostics Ltd. | 2014-02-01 |
| A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) (NCT01782131) | Merck Sharp & Dohme LLC | 2013-09-25 |
| Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections (NCT01105013) | Laboratório Teuto Brasileiro S/A | 2012-04-01 |
| Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547) (NCT01436578) | Merck Sharp & Dohme LLC | 2012-02-01 |
| Registry of Febrile Neutropenia and Invasive Fungal Infections (NCT01684189) | Chang Gung Memorial Hospital | 2011-11-01 |
| Studies of Disorders With Increased Susceptibility to Fungal Infections (NCT01222741) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-07 |
| Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) (NCT01777763) | Merck Sharp & Dohme LLC | 2009-06-01 |
| A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections (NCT00794703) | Astellas Pharma Inc | 2008-11-01 |
| A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579) (NCT01716234) | Merck Sharp & Dohme LLC | 2008-04-17 |
| A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant (NCT00606268) | Astellas Pharma Inc | 2007-11-01 |
| A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity (NCT00353158) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2007-05-25 |
| Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections (NCT00876096) | Centre Hospitalier Universitaire de Nice | 2007-02-01 |
| Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study (NCT00177710) | University of Pittsburgh | 2006-01-01 |
| Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) (NCT00177684) | University of Pittsburgh | 2004-09-01 |